We suggest that suppression and/or induction of COL4A1, PXDN, and TGFBI, and their molecular interplays involved in the ECM-related pathways may provide crucial clues to enhance the chemosensitivity of gastric cancer. The gene discussed is PXDN; the disease is gastric cancer.